Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231197476> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4231197476 endingPage "5055" @default.
- W4231197476 startingPage "5055" @default.
- W4231197476 abstract "5055 Background: In patients (pts) with advanced seminoma, efforts are underway to tailor a risk-adapted treatment strategy to the individual pt. Our main objective was to prospectively determine the prognostic value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT2) after two cycles of bleomycin, etoposide and cisplatin (BEP) or EP chemotherapy under standardized treatment and PET evaluation criteria. Methods: Pts with advanced-stage seminoma were treated with BEP or EP according to guidelines. PET/CT examinations were performed at baseline, after two cycles in all pts and after chemotherapy at physician’s choice. PET/CT response was qualitatively evaluated by two independent nuclear medicine physicians. Contrast-enhanced CT scans were also performed according to the guidelines (at baseline, after treatment, during follow-up). The primary endpoint was the relapse-free survival (RFS). Results: From 01/2009 to 01/2017, 75 consecutive pts were enrolled, of whom 70 were evaluable. The clinical stage was IIA-B and IIC-III in 40% and 60% of the pts, respectively. Eight pts (11.4%) received consolidation radiotherapy. By local assessment, 46 PET/CT2 scans (65.7%) were reported as negative, and 46% of these pts presented with stage IIC-III. The median follow-up was 79 months. Five-year RFS of PET/CT2-positive pts was 75% (95%CI: 60-95%) compared with 97.8% (95%CI: 93.7-100%) of PET/CT2-negative pts (p = .002). This significant improvement in RFS was maintained when analyzing only pts with clinical stage IIC-III (p = 0.04) and by excluding those who received consolidation RT (p = 0.02). An increasing linear association was found between the maximum diameter of retroperitoneal lymph nodes and the rate of PET/CT2+. In univariable Cox regression analyses, PET/CT2+ (HR: 12.9, 95%CI: 1.5-106.9, p = 0.02) and elevated HCG levels (HR: 6.3, 95%CI: 1.2-32.3, p = 0.03) were significantly associated with RFS, whereas IGCCCG risk group was not (p = 0.1). PET/CT2 result was also associated with the tumor shrinkage post-BEP (p = 0.009), whereas complete response at CT did not predict the RFS (p = 0.3). Conclusions: No residual FDG-uptake after 2 cycles of conventional chemotherapy is prognostic in advanced seminoma, may outperform the utility of standard prognostic risk groups and may be more accurate to predict the RFS compared to standard response criteria. Benchmark RFS estimates for the design of the next clinical trials of chemotherapy de-escalation are offered." @default.
- W4231197476 created "2022-05-12" @default.
- W4231197476 creator A5000621664 @default.
- W4231197476 creator A5012466586 @default.
- W4231197476 creator A5023943436 @default.
- W4231197476 creator A5024905408 @default.
- W4231197476 creator A5052176654 @default.
- W4231197476 creator A5058849092 @default.
- W4231197476 creator A5074977948 @default.
- W4231197476 creator A5083331837 @default.
- W4231197476 creator A5086507632 @default.
- W4231197476 creator A5090061046 @default.
- W4231197476 date "2020-05-20" @default.
- W4231197476 modified "2023-10-17" @default.
- W4231197476 title "Prognostic role of early interim [18F] fluoro-deoxy-glucose positron emission tomography in patients with advanced seminoma undergoing standard treatment." @default.
- W4231197476 doi "https://doi.org/10.1200/jco.2020.38.15_suppl.5055" @default.
- W4231197476 hasPublicationYear "2020" @default.
- W4231197476 type Work @default.
- W4231197476 citedByCount "0" @default.
- W4231197476 crossrefType "journal-article" @default.
- W4231197476 hasAuthorship W4231197476A5000621664 @default.
- W4231197476 hasAuthorship W4231197476A5012466586 @default.
- W4231197476 hasAuthorship W4231197476A5023943436 @default.
- W4231197476 hasAuthorship W4231197476A5024905408 @default.
- W4231197476 hasAuthorship W4231197476A5052176654 @default.
- W4231197476 hasAuthorship W4231197476A5058849092 @default.
- W4231197476 hasAuthorship W4231197476A5074977948 @default.
- W4231197476 hasAuthorship W4231197476A5083331837 @default.
- W4231197476 hasAuthorship W4231197476A5086507632 @default.
- W4231197476 hasAuthorship W4231197476A5090061046 @default.
- W4231197476 hasConcept C126322002 @default.
- W4231197476 hasConcept C126838900 @default.
- W4231197476 hasConcept C146357865 @default.
- W4231197476 hasConcept C151730666 @default.
- W4231197476 hasConcept C203092338 @default.
- W4231197476 hasConcept C2775842073 @default.
- W4231197476 hasConcept C2776694085 @default.
- W4231197476 hasConcept C2778074268 @default.
- W4231197476 hasConcept C2778119113 @default.
- W4231197476 hasConcept C2989005 @default.
- W4231197476 hasConcept C509974204 @default.
- W4231197476 hasConcept C535046627 @default.
- W4231197476 hasConcept C71924100 @default.
- W4231197476 hasConcept C86803240 @default.
- W4231197476 hasConceptScore W4231197476C126322002 @default.
- W4231197476 hasConceptScore W4231197476C126838900 @default.
- W4231197476 hasConceptScore W4231197476C146357865 @default.
- W4231197476 hasConceptScore W4231197476C151730666 @default.
- W4231197476 hasConceptScore W4231197476C203092338 @default.
- W4231197476 hasConceptScore W4231197476C2775842073 @default.
- W4231197476 hasConceptScore W4231197476C2776694085 @default.
- W4231197476 hasConceptScore W4231197476C2778074268 @default.
- W4231197476 hasConceptScore W4231197476C2778119113 @default.
- W4231197476 hasConceptScore W4231197476C2989005 @default.
- W4231197476 hasConceptScore W4231197476C509974204 @default.
- W4231197476 hasConceptScore W4231197476C535046627 @default.
- W4231197476 hasConceptScore W4231197476C71924100 @default.
- W4231197476 hasConceptScore W4231197476C86803240 @default.
- W4231197476 hasIssue "15_suppl" @default.
- W4231197476 hasLocation W42311974761 @default.
- W4231197476 hasOpenAccess W4231197476 @default.
- W4231197476 hasPrimaryLocation W42311974761 @default.
- W4231197476 hasRelatedWork W12408570 @default.
- W4231197476 hasRelatedWork W14366270 @default.
- W4231197476 hasRelatedWork W15112652 @default.
- W4231197476 hasRelatedWork W16034276 @default.
- W4231197476 hasRelatedWork W16496319 @default.
- W4231197476 hasRelatedWork W20413464 @default.
- W4231197476 hasRelatedWork W20714511 @default.
- W4231197476 hasRelatedWork W20929017 @default.
- W4231197476 hasRelatedWork W5647462 @default.
- W4231197476 hasRelatedWork W7661019 @default.
- W4231197476 hasVolume "38" @default.
- W4231197476 isParatext "false" @default.
- W4231197476 isRetracted "false" @default.
- W4231197476 workType "article" @default.